Kissei Pharmaceutical Co., Ltd.
KSPHF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $15,610,000 | $11,160,000 | $79,252 | $106,154 |
| Dep. & Amort. | $4,615,000 | $4,254,000 | $30,928 | $30,642 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$727,000 | -$9,296,000 | -$41,195 | $772 |
| Other Non-Cash | -$12,977,000 | -$7,795,000 | -$6,747,985 | $1,395,432 |
| Operating Cash Flow | $6,521,000 | -$1,677,000 | -$50,273 | $12,594 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4,507,000 | -$1,201,000 | -$54,458 | -$46,998 |
| Net Acquisitions | $0 | $0 | $587 | $189 |
| Inv. Purchases | -$978,000 | -$2,400,000 | -$8,024 | -$47,294 |
| Inv. Sales/Matur. | $14,160,000 | $11,902,000 | $106,108 | $181,946 |
| Other Inv. Act. | -$3,723,000 | $389,000 | $5,956,786 | $10,688,157 |
| Investing Cash Flow | $4,952,000 | $8,690,000 | $6,001,000 | $10,776,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$60,000 | -$150,000 | -$150,000 | -$103,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$5,293,000 | -$6,000,000 | $0 | $0 |
| Dividends Paid | -$3,801,000 | -$3,722,000 | -$3,135,000 | -$2,536,000 |
| Other Fin. Act. | -$171,000 | -$134,000 | -$135,000 | -$117,000 |
| Financing Cash Flow | -$9,325,000 | -$10,006,000 | -$3,420,000 | -$2,756,000 |
| Forex Effect | $27,000 | -$3,000 | -$21,000 | $4,000 |
| Net Chg. in Cash | $2,271,000 | -$2,997,000 | $121,393 | $9,557,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $45,887,000 | $48,884,000 | $246,557 | $393,186 |
| End Cash | $48,158,000 | $45,887,000 | $367,950 | $246,557 |
| Free Cash Flow | $1,491,000 | -$3,510,000 | -$104,731 | -$34,404 |